scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.PARKRELDIS.2012.03.024 |
P698 | PubMed publication ID | 22525366 |
P50 | author | Taku Hatano | Q42320293 |
Nobutaka Hattori | Q64780524 | ||
P2093 | author name string | Shigeto Sato | |
Shin-Ichiro Kubo | |||
Fumihiko Sakai | |||
Kazuko Hasegawa | |||
Saburo Yagishita | |||
Satoshi Imai | |||
Toshiki Uchihara | |||
Hisayuki Kowa | |||
Sachiko Ujiie | |||
P433 | issue | 7 | |
P921 | main subject | pathology | Q7208 |
P1104 | number of pages | 5 | |
P304 | page(s) | 819-823 | |
P577 | publication date | 2012-04-22 | |
P1433 | published in | Parkinsonism and Related Disorders | Q15762600 |
P1476 | title | LRRK2 I2020T mutation is associated with tau pathology | |
P478 | volume | 18 |
Q99711175 | A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2 |
Q92586724 | Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician |
Q38121773 | Advances in the genetics of Parkinson disease |
Q46441393 | Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease |
Q37590635 | Back to the tubule: microtubule dynamics in Parkinson's disease |
Q36325683 | Cellular effects of LRRK2 mutations |
Q33593798 | ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease |
Q29347540 | G2385R and I2020T Mutations Increase LRRK2 GTPase Activity |
Q94586186 | Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis |
Q38233866 | Genetics and genomics of Parkinson's disease |
Q27013695 | Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications |
Q38865951 | I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway |
Q30587398 | Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease |
Q51082143 | Interaction of LRRK2 and α-Synuclein in Parkinson's Disease. |
Q98177378 | LRRK2 and Protein Aggregation in Parkinson's Disease: Insights From Animal Models |
Q24338188 | LRRK2 phosphorylates novel tau epitopes and promotes tauopathy |
Q36888947 | LRRK2: an éminence grise of Wnt-mediated neurogenesis? |
Q37635000 | LRRK2: cause, risk, and mechanism |
Q48264748 | Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau. |
Q24338942 | Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β |
Q39104616 | Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways |
Q48177425 | Pathological and Clinical Spectrum of Progressive Supranuclear Palsy: With Special Reference to Astrocytic Tau Pathology |
Q21131229 | Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism |
Q59099056 | Physiological and pathological functions of LRRK2: implications from substrate proteins |
Q38214594 | Protein phosphorylation in neurodegeneration: friend or foe? |
Q60141582 | Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice |
Q38160939 | Targeting leucine-rich repeat kinase 2 in Parkinson's disease |
Q38482479 | The Role of α-Synuclein and LRRK2 in Tau Phosphorylation |
Q38229792 | The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies |
Q38111307 | The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease |
Q26991986 | The regulation and deregulation of Wnt signaling by PARK genes in health and disease |
Q38520438 | Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S. |
Search more.